Alpha Cognition Inc (ACOG)

$9.55 -0.20 (-2.05%)
Market Cap 212.34M
Revenue (ttm) 10.22M
Net Income (ttm) -20.67M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -202.25%
Debt to Equity Ratio 0.00
Volume 100,678
Avg Vol 100,040
Day's Range N/A - N/A
Shares Out 21.78M
Stochastic %K 82%
Beta 2.31
Analysts Strong Sell
Price Target $18.00

Company Profile

Alpha Cognition Inc., a biopharmaceutical company, engages in the development of treatments for patients suffering from neurodegenerative diseases in the United States and Canada. The company's commercial development program includes ZUNVEYL oral tablet formulation for treating Alzheimer's disease. Its pre-clinical development programs comprise ZUNVEYL in combination with memantine for the treatment of moderate-to-severe Alzheimer's disease; ALPHA-1062 sublingual formulation; ALPHA-1062 intranas...

Industry: Biotechnology
Sector: Healthcare
Phone: 858 344 4375
Address:
1452 Hughes Street, Suite 200, Grapevine, United States
History101
History101 Aug. 24 at 3:24 AM
$ACOG 406 watching Sun 8/23/2026
0 · Reply
GeorgeJonesFan_In_Boston
GeorgeJonesFan_In_Boston Aug. 22 at 3:29 PM
$ACOG Schwab still won’t let you buy online, only through phone calls. It’s been months.
0 · Reply
dixiebull
dixiebull Aug. 21 at 9:39 PM
$ACOG hits 10.10, stop under 6.50 now
0 · Reply
Zephix
Zephix Aug. 20 at 5:16 PM
$ACOG 10$+ pls
0 · Reply
endrow
endrow Aug. 20 at 5:12 PM
$ACOG Slowly but surely this company is starting to get the attention it deserves. In my opinion ACOG will be worth over a billion dollars by this time next year.
0 · Reply
Squicc
Squicc Aug. 20 at 11:58 AM
$ACOG
0 · Reply
BIGDADDYBENZ300
BIGDADDYBENZ300 Aug. 19 at 8:02 PM
$ACOG 200m market share is crazy. That drug will sell for 1-3B.
1 · Reply
Bioinvester001
Bioinvester001 Aug. 18 at 4:58 PM
$ACOG Adding, as this stock could see more big block trades. I think the institutions are starting to seriously look at this company, as the revenue stream is accelerating.
0 · Reply
FlowerInTheCellar
FlowerInTheCellar Aug. 17 at 8:34 PM
$ACOG https://www.newsfilecorp.com/release/309918 - Stonegate Capital Partners Updates Coverage on Alpha Cognition Inc. (ACOG) 2Q26
0 · Reply
focafoca99
focafoca99 Aug. 17 at 2:57 PM
$ACOG grows 2Q26 product revenue 71% to $6.0M as demand accelerates.
0 · Reply
Latest News on ACOG
Alpha Cognition initiated with a Buy at B. Riley

2026-08-20T08:15:23.000Z - 4 days ago

Alpha Cognition initiated with a Buy at B. Riley

Alpha Cognition initiated with a Buy at B. Riley

2026-08-20T01:15:13.000Z - 4 days ago

Alpha Cognition initiated with a Buy at B. Riley

Alpha Cognition price target raised to $20 from $18 at H.C. Wainwright

2026-08-17T15:25:07.000Z - 7 days ago

Alpha Cognition price target raised to $20 from $18 at H.C. Wainwright

Stonegate Capital Partners Updates Coverage on Alpha Cognition Inc. (ACOG) 2Q26

Aug 17, 2026, 10:43 AM EDT - 7 days ago

Stonegate Capital Partners Updates Coverage on Alpha Cognition Inc. (ACOG) 2Q26

Alpha Cognition reports Q2 EPS (40c), consensus (39c)

2026-08-16T14:10:29.000Z - 8 days ago

Alpha Cognition reports Q2 EPS (40c), consensus (39c)

Alpha Cognition price target raised to $17 from $14 at Craig-Hallum

2026-08-16T13:11:37.000Z - 8 days ago

Alpha Cognition price target raised to $17 from $14 at Craig-Hallum

Alpha Cognition Earnings Call Transcript: Q2 2026

Aug 13, 2026, 4:30 PM EDT - 10 days ago

Alpha Cognition Earnings Call Transcript: Q2 2026

Alpha Cognition Earnings release: Q2 2026

Aug 13, 2026, 4:30 PM EDT - 10 days ago

Alpha Cognition Earnings release: Q2 2026

Alpha Cognition Quarterly report: Q2 2026

Aug 13, 2026, 4:30 PM EDT - 10 days ago

Alpha Cognition Quarterly report: Q2 2026

Alpha Cognition Inc. Reports Second Quarter 2026 Financial Results and Provides Operational Update

Aug 13, 2026, 4:05 PM EDT - 10 days ago

Alpha Cognition Inc. Reports Second Quarter 2026 Financial Results and Provides Operational Update

Alpha Cognition Slides: Corporate presentation

Aug 13, 2026, 7:00 AM EDT - 11 days ago

Alpha Cognition Slides: Corporate presentation

Alpha Cognition Inc trading resumes

2026-08-03T14:10:11.000Z - 21 days ago

Alpha Cognition Inc trading resumes

Alpha Cognition Inc trading halted, volatility trading pause

2026-08-03T14:06:23.000Z - 21 days ago

Alpha Cognition Inc trading halted, volatility trading pause

Alpha Cognition to Report Second Quarter 2026 Financial Results and Provide Business Update

Aug 3, 2026, 8:30 AM EDT - 21 days ago

Alpha Cognition to Report Second Quarter 2026 Financial Results and Provide Business Update

Alpha Cognition announces EPO granted patent covering benzgalantamine

2026-07-29T12:35:47.000Z - 26 days ago

Alpha Cognition announces EPO granted patent covering benzgalantamine

Alpha Cognition Receives European Patent Covering ZUNVEYL® for the Treatment of Mild-to-Moderate Alzheimer's Disease

Jul 29, 2026, 8:30 AM EDT - 26 days ago

Alpha Cognition Receives European Patent Covering ZUNVEYL® for the Treatment of Mild-to-Moderate Alzheimer's Disease

Alpha Cognition to Participate in Panel Discussion at the B. Riley Securities Mind, Muscle & Vision Summit

Jul 10, 2026, 8:30 AM EDT - 6 weeks ago

Alpha Cognition to Participate in Panel Discussion at the B. Riley Securities Mind, Muscle & Vision Summit

Alpha Cognition initiated with an Outperform at Raymond James

2026-07-10T10:15:18.000Z - 6 weeks ago

Alpha Cognition initiated with an Outperform at Raymond James

Alpha Cognition appoints Robert Wills as chairman of the board

2026-06-23T17:04:49.000Z - 2 months ago

Alpha Cognition appoints Robert Wills as chairman of the board

Alpha Cognition Announces Election of Dr. Robert Wills as Chairman of the Board

Jun 23, 2026, 8:30 AM EDT - 2 months ago

Alpha Cognition Announces Election of Dr. Robert Wills as Chairman of the Board

Alpha Cognition announces enrollment of first patient in Resolve

2026-06-16T12:39:44.000Z - 2 months ago

Alpha Cognition announces enrollment of first patient in Resolve

Alpha Cognition Announces First Patient Enrolled in RESOLVE Phase 4 Study Evaluating ZUNVEYL® in Patients with Mild to Moderate Alzheimer's Disease

Jun 16, 2026, 8:30 AM EDT - 2 months ago

Alpha Cognition Announces First Patient Enrolled in RESOLVE Phase 4 Study Evaluating ZUNVEYL® in Patients with Mild to Moderate Alzheimer's Disease

Alpha Cognition reports results from Beacon real-world study of Zunevyl

2026-06-09T12:05:39.000Z - 2 months ago

Alpha Cognition reports results from Beacon real-world study of Zunevyl

Alpha Cognition Reports Positive Top-Line Results from BEACON Real-World Study of ZUNVEYL® in Alzheimer's Disease

Jun 9, 2026, 8:00 AM EDT - 2 months ago

Alpha Cognition Reports Positive Top-Line Results from BEACON Real-World Study of ZUNVEYL® in Alzheimer's Disease

Maxim starts Alpha Cognition at Buy, sees ‘significant’ market opportunity

2026-05-29T14:26:06.000Z - 3 months ago

Maxim starts Alpha Cognition at Buy, sees ‘significant’ market opportunity

Alpha Cognition initiated with a Buy at Maxim

2026-05-29T12:00:51.000Z - 3 months ago

Alpha Cognition initiated with a Buy at Maxim

Alpha Cognition Slides: Corporate presentation

May 16, 2026, 7:00 AM EDT - 3 months ago

Alpha Cognition Slides: Corporate presentation

Alpha Cognition reports Q1 EPS (32c) vs (11c) last year

2026-05-14T20:57:06.000Z - 3 months ago

Alpha Cognition reports Q1 EPS (32c) vs (11c) last year

Alpha Cognition Earnings Call Transcript: Q1 2026

May 14, 2026, 4:30 PM EDT - 3 months ago

Alpha Cognition Earnings Call Transcript: Q1 2026

Alpha Cognition Quarterly report: Q1 2026

May 14, 2026, 4:30 PM EDT - 3 months ago

Alpha Cognition Quarterly report: Q1 2026

Alpha Cognition Earnings release: Q1 2026

May 14, 2026, 4:30 PM EDT - 3 months ago

Alpha Cognition Earnings release: Q1 2026

Alpha Cognition Inc. Reports First Quarter 2026 Financial Results and Provides Operational Update

May 14, 2026, 4:15 PM EDT - 3 months ago

Alpha Cognition Inc. Reports First Quarter 2026 Financial Results and Provides Operational Update

Alpha Cognition Proxy statement: Proxy filing

Apr 30, 2026, 8:00 AM EDT - 4 months ago

Alpha Cognition Proxy statement: Proxy filing

Alpha Cognition Proxy statement: Proxy filing

Apr 30, 2026, 8:00 AM EDT - 4 months ago

Alpha Cognition Proxy statement: Proxy filing

Alpha Cognition (Nasdaq: ACOG) to Report First Quarter 2026 Financial Results and Provide Business Update on Thursday, May 14, 2026

Apr 28, 2026, 4:30 PM EDT - 4 months ago

Alpha Cognition (Nasdaq: ACOG) to Report First Quarter 2026 Financial Results and Provide Business Update on Thursday, May 14, 2026

Alpha Cognition Inc. to Participate in Three Upcoming Investor Conferences

Apr 27, 2026, 8:00 AM EDT - 4 months ago

Alpha Cognition Inc. to Participate in Three Upcoming Investor Conferences

Alpha Cognition Strengthens Its Board of Directors with Appointment of Bethany Sensenig

Apr 20, 2026, 5:00 PM EDT - 4 months ago

Alpha Cognition Strengthens Its Board of Directors with Appointment of Bethany Sensenig

Craig-Hallum bullish on Alpha Cognition, initiates with a Buy

2026-04-17T12:11:39.000Z - 4 months ago

Craig-Hallum bullish on Alpha Cognition, initiates with a Buy

Alpha Cognition initiated with a Buy at Craig-Hallum

2026-04-17T11:38:54.000Z - 4 months ago

Alpha Cognition initiated with a Buy at Craig-Hallum

Alpha Cognition Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Apr 15, 2026, 8:00 PM EDT - 4 months ago

Alpha Cognition Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Alpha Cognition granted U.S. patent for ALPHA-1062 in brain injury

2026-04-01T20:37:03.000Z - 5 months ago

Alpha Cognition granted U.S. patent for ALPHA-1062 in brain injury

Alpha Cognition Receives Issued U.S. Patent for ALPHA-1062 for Treatment of Traumatic Brain Injury

Apr 1, 2026, 4:30 PM EDT - 5 months ago

Alpha Cognition Receives Issued U.S. Patent for ALPHA-1062 for Treatment of Traumatic Brain Injury

Stonegate Capital Partners Updates Coverage on Alpha Cognition Inc. (ACOG) Q425

Apr 1, 2026, 9:51 AM EDT - 5 months ago

Stonegate Capital Partners Updates Coverage on Alpha Cognition Inc. (ACOG) Q425

Alpha Cognition Slides: Corporate presentation

Mar 27, 2026, 8:00 AM EDT - 5 months ago

Alpha Cognition Slides: Corporate presentation

Alpha Cognition Earnings Call Transcript: Q4 2025

Mar 26, 2026, 4:30 PM EDT - 5 months ago

Alpha Cognition Earnings Call Transcript: Q4 2025

Alpha Cognition Annual report: Q4 2025

Mar 26, 2026, 4:30 PM EDT - 5 months ago

Alpha Cognition Annual report: Q4 2025

Alpha Cognition Earnings release: Q4 2025

Mar 26, 2026, 4:30 PM EDT - 5 months ago

Alpha Cognition Earnings release: Q4 2025

Alpha Cognition Inc. Reports Fiscal 2025 Financial Results and Provides Operational Update

Mar 26, 2026, 4:01 PM EDT - 5 months ago

Alpha Cognition Inc. Reports Fiscal 2025 Financial Results and Provides Operational Update

Alpha Cognition (Nasdaq: ACOG) to Report Fourth Quarter and Full Year 2025 Financial Results and Provide Business Update on Thursday, March 26, 2026

Mar 13, 2026, 1:46 PM EDT - 5 months ago

Alpha Cognition (Nasdaq: ACOG) to Report Fourth Quarter and Full Year 2025 Financial Results and Provide Business Update on Thursday, March 26, 2026

Alpha Cognition to Present New Clinical on ZUNVEYL® (Benzgalantamine) at Multiple Upcoming Alzheimer's Association International Conferences

Mar 10, 2026, 8:30 AM EDT - 5 months ago

Alpha Cognition to Present New Clinical on ZUNVEYL® (Benzgalantamine) at Multiple Upcoming Alzheimer's Association International Conferences

Alpha Cognition Announces First Patient Enrolled in BEACON Real-World Effectiveness Study

Feb 25, 2026, 8:30 AM EST - 6 months ago

Alpha Cognition Announces First Patient Enrolled in BEACON Real-World Effectiveness Study

Alpha Cognition Announces Issuance of Additional U.S. Patent Covering ZUNVEYL ® Dosing Regimens

Feb 18, 2026, 8:30 AM EST - 6 months ago

Alpha Cognition Announces Issuance of Additional U.S. Patent Covering ZUNVEYL ® Dosing Regimens

Alpha Cognition Provides 2026 Corporate Update Highlighting Strategic Priorities and 2025 Commercial Execution

Jan 7, 2026, 4:30 PM EST - 8 months ago

Alpha Cognition Provides 2026 Corporate Update Highlighting Strategic Priorities and 2025 Commercial Execution

Alpha Cognition Transcript: Fireside Chat

Dec 2, 2025, 12:00 PM EST - 9 months ago

Alpha Cognition Transcript: Fireside Chat

Alpha Cognition to Participate in Virtual Fireside Chat Hosted by Titan Partners

Dec 1, 2025, 5:51 PM EST - 9 months ago

Alpha Cognition to Participate in Virtual Fireside Chat Hosted by Titan Partners

Stonegate Capital Partners Updates Coverage on Alpha Cognition Inc. (ACOG) Q3 2025

Nov 14, 2025, 9:46 AM EST - 10 months ago

Stonegate Capital Partners Updates Coverage on Alpha Cognition Inc. (ACOG) Q3 2025

Alpha Cognition Earnings Call Transcript: Q3 2025

Nov 13, 2025, 4:30 PM EST - 10 months ago

Alpha Cognition Earnings Call Transcript: Q3 2025

Alpha Cognition Earnings release: Q3 2025

Nov 13, 2025, 4:30 PM EST - 10 months ago

Alpha Cognition Earnings release: Q3 2025

Alpha Cognition Quarterly report: Q3 2025

Nov 13, 2025, 4:30 PM EST - 10 months ago

Alpha Cognition Quarterly report: Q3 2025

Alpha Cognition Inc. Reports Third Quarter 2025 Financial Results and Provides Operational Update

Nov 13, 2025, 4:00 PM EST - 10 months ago

Alpha Cognition Inc. Reports Third Quarter 2025 Financial Results and Provides Operational Update

Alpha Cognition Slides: Corporate Presentation

Nov 12, 2025, 6:00 PM EST - 10 months ago

Alpha Cognition Slides: Corporate Presentation

Alpha Cognition (Nasdaq: ACOG) to Report Third Quarter 2025 Financial Results and Provide Business Update on Thursday, November 13, 2025

Oct 30, 2025, 8:30 AM EDT - 10 months ago

Alpha Cognition (Nasdaq: ACOG) to Report Third Quarter 2025 Financial Results and Provide Business Update on Thursday, November 13, 2025

Alpha Cognition to Present Clinical Data at Consultant Pharmacy and Neuroscience Education Institute Meetings

Oct 14, 2025, 4:30 PM EDT - 11 months ago

Alpha Cognition to Present Clinical Data at Consultant Pharmacy and Neuroscience Education Institute Meetings

Alpha Cognition Transcript: Noble Capital Markets Emerging Growth Virtual Investor Conference

Oct 8, 2025, 8:30 AM EDT - 11 months ago

Alpha Cognition Transcript: Noble Capital Markets Emerging Growth Virtual Investor Conference

Alpha Cognition to Present Clinical Data at ASCP Annual Meeting

Oct 6, 2025, 8:30 AM EDT - 11 months ago

Alpha Cognition to Present Clinical Data at ASCP Annual Meeting

Alpha Cognition Inc. Announces Pricing of $35 Million Oversubscribed Public Offering of Common Shares

Sep 30, 2025, 11:14 PM EDT - 11 months ago

Alpha Cognition Inc. Announces Pricing of $35 Million Oversubscribed Public Offering of Common Shares

Alpha Cognition Inc. Announces Proposed Public Offering of Common Shares

Sep 30, 2025, 4:58 PM EDT - 11 months ago

Alpha Cognition Inc. Announces Proposed Public Offering of Common Shares

Alpha Cognition Inc. (Nasdaq: ACOG) Announces Participation in Key September Investor Conferences

Aug 28, 2025, 1:00 PM EDT - 1 year ago

Alpha Cognition Inc. (Nasdaq: ACOG) Announces Participation in Key September Investor Conferences

Alpha Cognition Registration statement: Registration Filing

Aug 22, 2025, 8:00 AM EDT - 1 year ago

Alpha Cognition Registration statement: Registration Filing

Stonegate Capital Partners Updates Coverage on Alpha Cognition Inc. (ACOG) Q2 2025

Aug 15, 2025, 5:10 PM EDT - 1 year ago

Stonegate Capital Partners Updates Coverage on Alpha Cognition Inc. (ACOG) Q2 2025

Alpha Cognition Earnings Call Transcript: Q2 2025

Aug 14, 2025, 4:30 PM EDT - 1 year ago

Alpha Cognition Earnings Call Transcript: Q2 2025

Alpha Cognition Earnings release: Q2 2025

Aug 14, 2025, 4:30 PM EDT - 1 year ago

Alpha Cognition Earnings release: Q2 2025

Alpha Cognition Quarterly report: Q2 2025

Aug 14, 2025, 4:30 PM EDT - 1 year ago

Alpha Cognition Quarterly report: Q2 2025

Alpha Cognition Inc. Reports Second Quarter 2025 Financial Results and Provides Operational Update

Aug 14, 2025, 8:30 AM EDT - 1 year ago

Alpha Cognition Inc. Reports Second Quarter 2025 Financial Results and Provides Operational Update

Alpha Cognition to Report Second Quarter 2025 Financial Results and Operating Overview

Aug 4, 2025, 8:30 AM EDT - 1 year ago

Alpha Cognition to Report Second Quarter 2025 Financial Results and Operating Overview

Alpha Cognition Announces Partner China Medical System Has NDA Accepted in China for the Review of ZUNVEYL® (Benzgalantamine) for Alzheimer's Disease

Jul 29, 2025, 8:30 AM EDT - 1 year ago

Alpha Cognition Announces Partner China Medical System Has NDA Accepted in China for the Review of ZUNVEYL® (Benzgalantamine) for Alzheimer's Disease

Alpha Cognition Registration statement: Registration Filing

Jul 21, 2025, 8:00 AM EDT - 1 year ago

Alpha Cognition Registration statement: Registration Filing

Alpha Cognition Slides: Investor Presentation

Jul 15, 2025, 6:00 PM EDT - 1 year ago

Alpha Cognition Slides: Investor Presentation

Alpha Cognition to Present ZUNVEYL® (Benzgalantamine) Study Data at Alzheimer's Association International Conference

Jul 8, 2025, 8:30 AM EDT - 1 year ago

Alpha Cognition to Present ZUNVEYL® (Benzgalantamine) Study Data at Alzheimer's Association International Conference

Alpha Cognition Announces Positive Pre-Clinical Data for ALPHA-1062 Use in a Military Relevant Model of Repetitive Mild Traumatic Brain Injury

Jul 1, 2025, 5:05 PM EDT - 1 year ago

Alpha Cognition Announces Positive Pre-Clinical Data for ALPHA-1062 Use in a Military Relevant Model of Repetitive Mild Traumatic Brain Injury

Alpha Cognition Registration statement: Registration Filing

Jul 1, 2025, 8:00 AM EDT - 1 year ago

Alpha Cognition Registration statement: Registration Filing

Stonegate Capital Partners Updates Coverage on Alpha Cognition Inc. (ACOG) Q1 2025

May 19, 2025, 10:25 AM EDT - 1 year ago

Stonegate Capital Partners Updates Coverage on Alpha Cognition Inc. (ACOG) Q1 2025

Alpha Cognition Earnings Call Transcript: Q1 2025

May 15, 2025, 4:30 PM EDT - 1 year ago

Alpha Cognition Earnings Call Transcript: Q1 2025

Alpha Cognition Earnings release: Q1 2025

May 15, 2025, 4:30 PM EDT - 1 year ago

Alpha Cognition Earnings release: Q1 2025

Alpha Cognition Quarterly report: Q1 2025

May 15, 2025, 4:30 PM EDT - 1 year ago

Alpha Cognition Quarterly report: Q1 2025

Alpha Cognition Inc. Reports First Quarter 2025 Financial Results and Operating Overview

May 15, 2025, 8:30 AM EDT - 1 year ago

Alpha Cognition Inc. Reports First Quarter 2025 Financial Results and Operating Overview

Alpha Cognition Proxy statement: Proxy Filing

May 6, 2025, 8:00 AM EDT - 1 year ago

Alpha Cognition Proxy statement: Proxy Filing

Alpha Cognition Proxy statement: Proxy Filing

May 6, 2025, 8:00 AM EDT - 1 year ago

Alpha Cognition Proxy statement: Proxy Filing

Alpha Cognition to Report First Quarter 2025 Financial Results and Operating Overview

May 1, 2025, 8:30 AM EDT - 1 year ago

Alpha Cognition to Report First Quarter 2025 Financial Results and Operating Overview

Alpha Cognition Proxy statement: Proxy Filing

Apr 30, 2025, 8:00 AM EDT - 1 year ago

Alpha Cognition Proxy statement: Proxy Filing

Alpha Cognition, Inc. Announces Participation in the D. Boral Capital Inaugural Global Conference

Apr 30, 2025, 7:30 AM EDT - 1 year ago

Alpha Cognition, Inc. Announces Participation in the D. Boral Capital Inaugural Global Conference

Alpha Cognition to Present ZUNVEYL® (Benzgalantamine) Clinical Data at 2025 Alzheimer's Association International Conference

Apr 28, 2025, 8:30 AM EDT - 1 year ago

Alpha Cognition to Present ZUNVEYL® (Benzgalantamine) Clinical Data at 2025 Alzheimer's Association International Conference

Alpha Cognition Strengthens Its Leadership Team with Appointment of Robert Wills to Board of Directors and Announces Departure of Existing Director John Havens

Apr 10, 2025, 8:30 AM EDT - 1 year ago

Alpha Cognition Strengthens Its Leadership Team with Appointment of Robert Wills to Board of Directors and Announces Departure of Existing Director John Havens

Stonegate Capital Partners Updates Coverage on Alpha Cognition Inc. (ACOG) Q4 2024

Apr 1, 2025, 4:27 PM EDT - 1 year ago

Stonegate Capital Partners Updates Coverage on Alpha Cognition Inc. (ACOG) Q4 2024

Alpha Cognition Earnings Call Transcript: Q4 2024

Mar 31, 2025, 4:30 PM EDT - 1 year ago

Alpha Cognition Earnings Call Transcript: Q4 2024

Alpha Cognition Earnings release: Q4 2024

Mar 31, 2025, 4:30 PM EDT - 1 year ago

Alpha Cognition Earnings release: Q4 2024

Alpha Cognition Annual report: Q4 2024

Mar 31, 2025, 4:30 PM EDT - 1 year ago

Alpha Cognition Annual report: Q4 2024

Alpha Cognition Inc. Reports Fourth Quarter and Full Year 2024 Financial Results and Operating Overview

Mar 31, 2025, 8:30 AM EDT - 1 year ago

Alpha Cognition Inc. Reports Fourth Quarter and Full Year 2024 Financial Results and Operating Overview

Alpha Cognition to Report Fourth Quarter and Full Year 2024 Financial Results and Operating Overview

Mar 19, 2025, 4:30 PM EDT - 1 year ago

Alpha Cognition to Report Fourth Quarter and Full Year 2024 Financial Results and Operating Overview

Alpha Cognition Slides: Corporate Presentation

Mar 19, 2025, 8:00 AM EDT - 1 year ago

Alpha Cognition Slides: Corporate Presentation

Alpha Cognition Announces the Commercial Launch of ZUNVEYL (Benzgalantamine) for the Treatment of Mild to Moderate Alzheimer's Disease

Mar 18, 2025, 8:30 AM EDT - 1 year ago

Alpha Cognition Announces the Commercial Launch of ZUNVEYL (Benzgalantamine) for the Treatment of Mild to Moderate Alzheimer's Disease

Alpha Cognition Secures Additional U.S. Patent for ZUNVEYL (benzgalantamine) in the Treatment of Mild to Moderate Alzheimer's disease

Feb 12, 2025, 8:30 AM EST - 1 year ago

Alpha Cognition Secures Additional U.S. Patent for ZUNVEYL (benzgalantamine) in the Treatment of Mild to Moderate Alzheimer's disease

Stonegate Capital Partners Initiates Coverage on Alpha Cognition Inc. (ACOG)

Jan 30, 2025, 11:05 AM EST - 1 year ago

Stonegate Capital Partners Initiates Coverage on Alpha Cognition Inc. (ACOG)

Alpha Cognition Transcript: Investor Update

Jan 28, 2025, 4:00 PM EST - 1 year ago

Alpha Cognition Transcript: Investor Update

Alpha Cognition Slides: Investor Update

Jan 28, 2025, 4:00 PM EST - 1 year ago

Alpha Cognition Slides: Investor Update

Alpha Cognition Expands Commercial and Medical Teams with Key Leadership Hires to Support the Launch of ZUNVEYL

Jan 14, 2025, 8:30 AM EST - 1 year ago

Alpha Cognition Expands Commercial and Medical Teams with Key Leadership Hires to Support the Launch of ZUNVEYL

Alpha Cognition Registration statement: Registration Filing

Jan 10, 2025, 7:00 AM EST - 1 year ago

Alpha Cognition Registration statement: Registration Filing

Alpha Cognition Announces a $44 Million Exclusive Licensing Agreement for the Development and Commercialization of ZUNVEYL (benzgalantamine), an FDA-Approved Treatment for Mild-to-Moderate Alzheimer's Disease, in China

Jan 8, 2025, 8:30 AM EST - 1 year ago

Alpha Cognition Announces a $44 Million Exclusive Licensing Agreement for the Development and Commercialization of ZUNVEYL (benzgalantamine), an FDA-Approved Treatment for Mild-to-Moderate Alzheimer's Disease, in China

History101
History101 Aug. 24 at 3:24 AM
$ACOG 406 watching Sun 8/23/2026
0 · Reply
GeorgeJonesFan_In_Boston
GeorgeJonesFan_In_Boston Aug. 22 at 3:29 PM
$ACOG Schwab still won’t let you buy online, only through phone calls. It’s been months.
0 · Reply
dixiebull
dixiebull Aug. 21 at 9:39 PM
$ACOG hits 10.10, stop under 6.50 now
0 · Reply
Zephix
Zephix Aug. 20 at 5:16 PM
$ACOG 10$+ pls
0 · Reply
endrow
endrow Aug. 20 at 5:12 PM
$ACOG Slowly but surely this company is starting to get the attention it deserves. In my opinion ACOG will be worth over a billion dollars by this time next year.
0 · Reply
Squicc
Squicc Aug. 20 at 11:58 AM
$ACOG
0 · Reply
BIGDADDYBENZ300
BIGDADDYBENZ300 Aug. 19 at 8:02 PM
$ACOG 200m market share is crazy. That drug will sell for 1-3B.
1 · Reply
Bioinvester001
Bioinvester001 Aug. 18 at 4:58 PM
$ACOG Adding, as this stock could see more big block trades. I think the institutions are starting to seriously look at this company, as the revenue stream is accelerating.
0 · Reply
FlowerInTheCellar
FlowerInTheCellar Aug. 17 at 8:34 PM
$ACOG https://www.newsfilecorp.com/release/309918 - Stonegate Capital Partners Updates Coverage on Alpha Cognition Inc. (ACOG) 2Q26
0 · Reply
focafoca99
focafoca99 Aug. 17 at 2:57 PM
$ACOG grows 2Q26 product revenue 71% to $6.0M as demand accelerates.
0 · Reply
LSOTradingDesk
LSOTradingDesk Aug. 16 at 11:01 AM
$ACOG 👀 watching but want to wait till the after earnings "glow" wears off we'll take closer look Wednesday and Thursday 🤔😁💰🦎
0 · Reply
endrow
endrow Aug. 14 at 4:25 PM
$ACOG This is a generational wealth making opportunity. Almost unbelievable that people are still missing this. The best oral Alzheimers drug on the market and the company is sitting at a $200 million valuation.
0 · Reply
Zephix
Zephix Aug. 13 at 11:46 PM
$ACOG
0 · Reply
StocktwitsEarnings
StocktwitsEarnings Aug. 13 at 10:13 PM
$ACOG Q2 '26 Earnings Results & Recap • Reported GAAP EPS of -$0.40 up 51.22% YoY • Reported revenue of $6.09M up 267.56% YoY
0 · Reply
JackCampbell
JackCampbell Aug. 13 at 9:32 PM
$ACOG thank you mgmnt team for the exceptional work this quarter!
0 · Reply
Shawshank_book_keeper
Shawshank_book_keeper Aug. 13 at 9:02 PM
$ACOG
0 · Reply
JackCampbell
JackCampbell Aug. 13 at 8:37 PM
$ACOG wow q2 revenue 6m vs 4.36m! Huge....
0 · Reply
FlowerInTheCellar
FlowerInTheCellar Aug. 13 at 8:30 PM
$ACOG https://www.businesswire.com/news/home/20260813925169/en/Alpha-Cognition-Inc.-Reports-Second-Quarter-2026-Financial-Results-and-Provides-Operational-Update
0 · Reply
Bioinvester001
Bioinvester001 Aug. 5 at 1:18 AM
$ACOG Grind up to earnings date is happening. Could see big news relative to the nasel spray for brain injuries. BO could be in play here as well.
1 · Reply
endrow
endrow Aug. 3 at 4:53 PM
$ACOG https://www.businesswire.com/news/home/20260803960737/en/Alpha-Cognition-to-Report-Second-Quarter-2026-Financial-Results-and-Provide-Business-Update
0 · Reply
JustBen47
JustBen47 Aug. 1 at 10:39 PM
$ACOG Has moved into commercialization, giving investors exposure to potential product revenue growth..
0 · Reply
FlowerInTheCellar
FlowerInTheCellar Jul. 29 at 5:48 PM
$ACOG https://www.businesswire.com/news/home/20260729160832/en/Alpha-Cognition-Receives-European-Patent-Covering-ZUNVEYL-for-the-Treatment-of-Mild-to-Moderate-Alzheimers-Disease 😉
1 · Reply